Literature DB >> 18782326

High mortality rate of (NZW x BXSB)F1 mice induced by administration of lipopolysaccharide attributes to high production of tumour necrosis factor-alpha by increased numbers of dendritic cells.

N Koike-Kiriyama1, Y Adachi, M Iwasaki, Y Amou, A Shigematsu, Y Koike, K Minamino, H Mukaide, M Shi, S Yanai, M Matsumura, S Ikehara.   

Abstract

(NZW x BXSB)F1 mice (W/BF1 mice) have been reported to be a type of autoimmune-prone mice, showing symptoms of proteinuria, anti-DNA antibodies and anti-platelet antibodies. In this paper, we report that W/BF1 mice show hyperproduction of tumour necrosis factor (TNF)-alpha, responding to lipopolysaccharide (LPS) in comparison with normal mice, resulting in induction of death. In normal mice, monocytes/macrophages (Mo/MØ) are the main producer of TNF-alpha, while both Mo/MØ and dendritic cells (DCs) produce TNF-alpha in W/BF1 mice. Because the number of DCs is higher in W/BF1 mice, the main producers of TNF-alpha in W/BF1 mice are thought to be DCs. Moreover, administration of anti-TNF-alpha antibodies rescued the W/BF1 mice from death induced by LPS, suggesting that TNF-alpha is crucial for the effect of LPS. Although there is no significant difference in the expression of Toll-like receptor-4 (TLR-4) on DCs between B6 and W/BF1 mice, nuclear factor kappa b activity of DCs from W/BF1 mice is augmented under stimulation of LPS in comparison with that of normal mice. These results suggest that the signal transduction from TLR-4 is augmented in W/BF1 mice in comparison with normal mice, resulting in the hyperproduction of TNF-alpha and reduced survival rate. The results also suggest that not only the quantity of endotoxin, but also the host conditions, the facility to translate signal from TLR, and so on, could reflect the degree of bacterial infections and prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782326      PMCID: PMC2612720          DOI: 10.1111/j.1365-2249.2008.03759.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  SOCS-1 participates in negative regulation of LPS responses.

Authors:  Reiko Nakagawa; Tetsuji Naka; Hiroko Tsutsui; Minoru Fujimoto; Akihiro Kimura; Tatsuo Abe; Ekihiro Seki; Shintaro Sato; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira; Koichi Yamanishi; Ichirou Kawase; Kenji Nakanishi; Tadamitsu Kishimoto
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

Review 3.  Innate immune sensing and its roots: the story of endotoxin.

Authors:  Bruce Beutler; Ernst Th Rietschel
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

4.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

5.  Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages.

Authors:  Yuichi Sekine; Taro Yumioka; Tetsuya Yamamoto; Ryuta Muromoto; Seiyu Imoto; Kenji Sugiyma; Kenji Oritani; Kazuya Shimoda; Mayu Minoguchi; Shizuo Akira; Akihiko Yoshimura; Tadashi Matsuda
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

6.  Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88.

Authors:  Sophie Janssens; Kim Burns; Jurg Tschopp; Rudi Beyaert
Journal:  Curr Biol       Date:  2002-03-19       Impact factor: 10.834

7.  Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study.

Authors:  W U Kim; J K Min; S H Lee; S H Park; C S Cho; H Y Kim
Journal:  Clin Exp Rheumatol       Date:  1999 Sep-Oct       Impact factor: 4.473

8.  Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo.

Authors:  B Pulendran; P Kumar; C W Cutler; M Mohamadzadeh; T Van Dyke; J Banchereau
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

9.  Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood.

Authors:  Dominique De Wit; Sandrine Tonon; Véronique Olislagers; Stanislas Goriely; Michaël Boutriaux; Michel Goldman; Fabienne Willems
Journal:  J Autoimmun       Date:  2003-11       Impact factor: 7.094

10.  Mouse CD11c(+) B220(+) Gr1(+) plasmacytoid dendritic cells develop independently of the T-cell lineage.

Authors:  Isabel Ferrero; Werner Held; Anne Wilson; Fabienne Tacchini-Cottier; Freddy Radtke; H Robson MacDonald
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

View more
  2 in total

1.  Dehydroxymethylepoxyquinomicin (DHMEQ) can suppress tumour necrosis factor-α production in lipopolysaccharide-injected mice, resulting in rescuing mice from death in vivo.

Authors:  T Shimo; Y Adachi; K Umezawa; M Okigaki; J Takaya; S Taniuchi; S Ikehara; K Kaneko
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1.

Authors:  Xiao-hui Li; Xia Gong; Li Zhang; Rong Jiang; Hong-zhong Li; Meng-jiao Wu; Jing-yuan Wan
Journal:  Mediators Inflamm       Date:  2013-01-30       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.